Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 28, 2019; 25(36): 5451-5468
Published online Sep 28, 2019. doi: 10.3748/wjg.v25.i36.5451
Published online Sep 28, 2019. doi: 10.3748/wjg.v25.i36.5451
Figure 1 Expression of AZGP1 in liver tissues of chronic hepatitis B and non-alcoholic fatty liver disease patients.
IHC-stained AZGP1 is showed in human liver tissues (A) of two chronic hepatitis B (CHB) and non-alcoholic fatty liver disease (NAFLD) patients. AZGP1 mRNA (B) and protein (C) expression is showed in liver tissues of another group of CHB and NAFLD patients (n = 3 each). aP < 0.05 vs CHB group. CHB: Chronic hepatitis B; NAFLD: Non-alcoholic fatty liver disease.
- Citation: Liu T, Luo X, Li ZH, Wu JC, Luo SZ, Xu MY. Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α. World J Gastroenterol 2019; 25(36): 5451-5468
- URL: https://www.wjgnet.com/1007-9327/full/v25/i36/5451.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i36.5451